MSC immune tolerance in cellular cardiomyoplasty

Seminars in Thoracic and Cardiovascular Surgery
Ray Chu-Jeng Chiu

Abstract

During the past several years, there have been increasing experimental and early clinical observations indicating that allogeneic, and even xenogeneic, mesenchymal stem cells (MSCs) may be useful for cellular cardiomyoplasty. Although the immune tolerance of MSCs is well established in various in vitro studies, controversies on the in vivo immune tolerance of MSCs persist. Confirmation of the feasibility of allogeneic cellular cardiomyoplasty will have vast clinical implications, since it will provide convenient "off-the-shelf" donor cells, as a vehicle for gene therapy, and avoid the need to use dysfunctional autologous MSCs in senile and/or disabled patients.

References

Jan 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·D W BianchiM A DeMaria
Apr 16, 2002·Science·Polly Matzinger
Jul 18, 2002·The Annals of Thoracic Surgery·Takayuki SaitoRay C J Chiu
Oct 21, 2004·Blood·Sudeepta Aggarwal, Mark F Pittenger
May 18, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Ray C J Chiu
Aug 3, 2005·Proceedings of the National Academy of Sciences of the United States of America·Luciano C AmadoJoshua M Hare
Apr 4, 2006·Annals of Medicine·Karl-Henrik GrinnemoGöran Dellgren
Aug 1, 2007·Blood·Alma J Nauta, Willem E Fibbe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

The American Heart Hospital Journal
Benedetta A Pallante, Jay M Edelberg
The Annals of Thoracic Surgery
Juan C ChachquesAlain F Carpentier
International Journal of Cardiology
Doris A Taylor
© 2022 Meta ULC. All rights reserved